Evidence map›Paper›PMID 30061704›Full record

ArticleScientific reports2018

High-throughput chemical screening to discover new modulators of microRNA expression in living cells by using graphene-based biosensor.

Soo-Ryoon Ryoo, Yeajee Yim, Young-Kwan Kim, Il-Soo Park, Hee-Kyung Na, Jieon Lee, Hongje Jang, Cheolhee Won, Sungwoo Hong, Sung-Yon Kim and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Reflections and Outlook on Multifaceted Biomedical Applications of Graphene.Advances in experimental medicine and biology · 2022
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Soo-Ryoon RyooDepartment of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0003-2798-0443
Yeajee YimDepartment of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.
Young-Kwan KimCarbon Composite Materials Research Center, Korea Institute of Science and Technology (KIST), Jeonbuk, 55324, Republic of Korea.
Il-Soo ParkDepartment of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.
Hee-Kyung NaCenter for Nano-Bio Measurement, Korea Research Institute of Standards and Science (KRISS), Daejeon, 34113, Republic of Korea.
Jieon LeePredictive Toxicology Department, Korea Institute of Toxicology (KIT), Daejeon, 34114, Republic of Korea.
Hongje JangDepartment of Chemistry, Kwangwoon University, 20 Gwangwoon-ro, Nowon-gu, Seoul, 01897, Republic of Korea.
Cheolhee WonInstitute of Biotherapeutics Convergence Technology, Lemonex Inc, Seoul, 08826, Republic of Korea.
Sungwoo HongDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
Sung-Yon KimDepartment of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0003-0791-7308
Noo Li JeonDepartment of Mechanical and Aerospace Engineering, Seoul National University, Seoul, 08826, South Korea.
Joon Myong SongCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0002-9896-5892
Dal-Hee MinDepartment of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea. dalheemin@snu.ac.kr.
Seoul National University · KRKorea Advanced Institute of Science and Technology · KRKorea Institute of Science and Technology · KRKorea Institute of Toxicology · KRKorea Research Institute of Standards and Science · KRKwangwoon University · KRLemonex (South Korea) · KR

Funding

National Research Foundation of Korea (NRF) 2014K1B1A1073716National Research Foundation of Korea (NRF) 2016R1A4A1010796National Research Foundation of Korea (NRF) 2016R1E1A1A01941202National Research Foundation of Korea (NRF) IBS-R008-D1
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are important regulatory RNAs that control gene expression in various biological processes. Therefore, control over the disease-related miRNA expression is important both for basic research and for a new class of therapeutic modality to treat serious diseases such as cancer. Here, we present a high-throughput screening strategy to identify small molecules that modulate miRNA expression in living cells. The screen enables simultaneous monitoring of the phenotypic cellular changes associated with the miRNA expression by measuring quantitative fluorescent signals corresponding to target miRNA level in living cells based on a novel biosensor composed of peptide nucleic acid and nano-sized graphene oxide. In this study, the biosensor based cellular screening of 967 compounds (including FDA-approved drugs, enzyme inhibitors, agonists, and antagonists) in cells identified four different classes of small molecules consisting of (i) 70 compounds that suppress both miRNA-21 (miR-21) expression and cell proliferation, (ii) 65 compounds that enhance miR-21 expression and reduce cell proliferation, (iii) 2 compounds that suppress miR-21 expression and increase cell proliferation, and (iv) 21 compounds that enhance both miR-21 expression and cell proliferation. We further investigated the hit compounds to correlate cell morphology changes and cell migration ability with decreased expression of miR-21.

Indexed as

Biosensing TechniquesCell Line, TumorCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticGraphiteHigh-Throughput Screening AssaysHumansMicroRNAsReproducibility of ResultsSmall Molecule LibrariesGraphiteMicroRNAsSmall Molecule Libraries

Identifiers

PMID30061704
PMCPMC6065314
OpenAlexW2884695264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.